Skip to main content
    E

    Equillium Inc (EQ)

    Official site

    HEALTHCARE • BIOTECHNOLOGY • NASDAQ

    $1.15
    -0.14 (-10.85%)

    Market Cap: $106.20M

    Last updated: Nov 17, 2026 at 11:05 AM ET

    Equillium Inc (EQ) Financials: Revenue, Profit and Cash Flow

    Updated Nov 12, 2026. Financial statements from company filings, amounts in US dollars.

    Equillium reported revenue of $130.00K for the fiscal year ended Dec 31, 2025, down 99.7% from the year before. That year, net income was -$22.40M with a net margin of -17229.2%, operating cash flow was -$22.75M and free cash flow was -$22.79M. The quarter ended Sep 30, 2026 had net income of -$4.58M.

    Revenue and Margins

    Fiscal yearRevenueGrowthGross marginOperating marginNet margin
    Dec 2025$130.00K-99.7%-89.2%-18180.0%-17229.2%
    Dec 2024$41.09M+13.9%100.0%-20.1%-19.6%
    Dec 2023$36.08M+129.0%100.0%-40.2%-37.0%
    Dec 2022$15.76MN/A100.0%-393.9%-396.1%
    Dec 2021$0N/AN/AN/AN/A
    Dec 2020$0N/AN/AN/AN/A
    Dec 2019$0N/AN/AN/AN/A
    Dec 2018$0N/AN/AN/AN/A
    Dec 2017$0N/AN/AN/AN/A
    Annual, fiscal years ended Dec 2017 to Dec 2025

    Income Statement

    In the fiscal year ended Dec 2025, the net loss widened from the year before. In the quarter ended Sep 2026, the net loss widened from the same quarter a year earlier.

    Annual

    Line itemDec 2025Dec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018Dec 2017
    Revenue$130.00K$41.09M$36.08M$15.76M$0$0$0$0$0
    Cost of revenue$116.00K$137.00K$126.00K$118.00K$72.00K$45.00K$23.00K$6.10K$122
    Gross profit-$116.00K$41.09M$36.08M$15.76M-$72.00K-$45.00K-$23.00K-$6.10K-$122
    Research and development$12.84M$37.43M$37.04M$37.55M$26.38M$19.38M$17.64M$4.94M$1.33M
    Operating income-$23.63M-$8.27M-$14.52M-$62.08M-$37.79M-$29.55M-$26.73M-$8.62M-$1.71M
    Net income-$22.40M-$8.07M-$13.34M-$62.43M-$38.98M-$29.77M-$25.58M-$13.25M-$2.26M
    EBITDA-$22.28M-$7.57M-$12.14M-$61.26M-$37.71M-$29.50M-$26.70M-$8.61MN/A
    Fiscal years ended Dec 2017 to Dec 2025

    Quarterly

    Line itemSep 2026Jun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023
    RevenueN/A$0$0$0$0$0$0$4.39M$12.16M$13.85M$10.69M$9.21M
    Gross profitN/AN/A-$24.00K-$23.00K-$28.00K-$32.00K-$33.00K$4.39M$12.16M$13.85M$10.66M$9.18M
    Operating income-$5.05M-$5.16M-$5.61M-$3.96M-$4.58M-$6.23M-$8.87M-$4.70M-$679.00K-$100.00K-$2.79M-$3.20M
    Net income-$4.58M-$4.69M-$5.31M-$3.77M-$4.23M-$5.74M-$8.65M-$5.79M-$7.00K$468.00K-$2.73M-$2.34M
    Last 12 quarters

    Balance Sheet

    As of Dec 2025, cash and equivalents exceeded short-term debt of $363.00K by $29.91M.

    Annual

    Line itemDec 2025Dec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018Dec 2017
    Total assets$31.89M$25.60M$50.53M$78.42M$85.41M$85.43M$55.54M$67.16M$7.15M
    Current assets$30.28M$24.98M$49.35M$76.73M$83.76M$85.43M$55.54M$67.16M$7.15M
    Cash and equivalents$30.28M$18.09M$23.22M$59.11M$50.37M$23.98M$13.22M$28.51M$7.10M
    Total liabilities$3.29M$6.54M$27.96M$46.48M$18.90M$15.57M$13.69M$2.23M$9.40M
    Short-term debt$363.00K$197.00K$440.00K$6.12M$1.80M$1.67MN/AN/A$8.06M
    Long-term debtN/AN/AN/A$3.24M$8.75M$8.28M$9.68M$200.00K$8.06M
    Shareholder equity$28.60M$19.06M$22.57M$31.94M$66.50M$69.85M$41.85M$64.94M-$2.25M
    Fiscal years ended Dec 2017 to Dec 2025

    Quarterly

    Line itemSep 2026Jun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023
    Total assets$55.81M$58.67M$63.08M$31.89M$34.51M$12.40M$16.73M$25.60M$34.46M$42.86M$43.60M$50.53M
    Total liabilities$3.13M$2.65M$3.60M$3.29M$3.57M$7.34M$6.15M$6.54M$11.28M$20.43M$22.50M$27.96M
    Cash and equivalents$53.32M$57.16M$61.32M$30.28M$33.12M$11.49M$14.50M$18.09M$15.45M$11.06M$11.57M$23.22M
    Shareholder equity$52.68M$56.02M$59.49M$28.60M$30.94M$5.06M$10.58M$19.06M$23.18M$22.43M$21.09M$22.57M
    Last 12 quarters

    Cash Flow

    Operating cash flow was negative in the fiscal year ended Dec 2025.

    Annual

    Line itemDec 2025Dec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018Dec 2017
    Operating cash flow-$22.75M-$19.03M-$21.78M-$8.73M-$32.08M-$24.62M-$22.95M-$7.53M-$662.20K
    Capital expenditures$48.00K$85.00K$50.00K$279.00K$57.00K$202.00K$74.00K$34.86K$2.20K
    Free cash flow-$22.79M-$19.11M-$21.83M-$9.01M-$32.14M-$24.83M-$23.02M-$7.56M-$664.40K
    Dividends paidN/AN/A$9.13MN/AN/AN/A$9.88MN/AN/A
    Investing cash flow$4.46M$13.81M-$4.76M$18.68M$27.41M-$18.59M-$2.17M-$37.43M-$2.20K
    Financing cash flow$30.43M$164.00K-$9.23M-$1.22M$31.06M$53.95M$9.84M$66.37M$7.77M
    Fiscal years ended Dec 2017 to Dec 2025

    Quarterly

    Line itemSep 2026Jun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023
    Operating cash flow-$3.83M-$4.11M-$4.30M-$3.13M-$8.43M-$3.01M-$8.17M-$3.30M-$7.66M$730.00K-$8.80M-$5.66M
    Capital expenditures$0$71.00K$3.00K$44.00K$0$0$4.00K$4.00K$0$62.00K$19.00K$35.00K
    Free cash flow-$3.83M-$4.18M-$4.30M-$3.18M-$8.43M-$3.01M-$8.17M-$3.30M-$7.66M$668.00K-$8.82M-$5.70M
    Last 12 quarters

    Frequently Asked Questions About EQ

    What is Equillium's annual revenue?

    Equillium reported revenue of $130.00K for the fiscal year ended Dec 31, 2025.

    How fast is Equillium's revenue growing?

    Revenue was down 99.7% for the fiscal year ended Dec 31, 2025 compared with the year before. The compound annual revenue growth rate over 3 years was -79.8%.

    Is Equillium profitable?

    No. Equillium reported net income of -$22.40M for the fiscal year ended Dec 31, 2025, with a net margin of -17229.2%.

    How much free cash flow does EQ generate?

    For the fiscal year ended Dec 31, 2025, operating cash flow of -$22.75M minus capital expenditures of $48.00K produced free cash flow of -$22.79M.

    How much debt does Equillium have?

    The balance sheet dated Dec 31, 2025 reported short-term debt of $363.00K and cash and equivalents of $30.28M.